Platelet dysfunction in a large-animal model of endotoxic shock; effects of inhaled nitric oxide and low-dose steroid

• Published in: Nitric oxide 2021-03, Vol.108, p.20-27
• Main Authors: Adamik, Barbara, Frostell, Claes, Paslawska, Urszula, Dragan, Barbara, Zielinski, Stanislaw, Paslawski, Robert, Janiszewski, Adrian, Zielinska, Marzena, Ryniak, Stanislaw, Ledin, Gustaf, Gozdzik, Waldemar
• Format: Article
• Language: English
• Subjects: Aggregometry; Endotoxemia; Inhaled nitric oxide; Medicin och hälsovetenskap; Platelets; Pulmonary hypertension; Shock
• ISSN: 1089-8603; 1089-8611; 1089-8611
• DOI: 10.1016/j.niox.2020.12.008

The role of inhaled nitric oxide in the treatment of shock remains controversial and further translational research is needed. Long-term observation studies using a model of endotoxin-induced shock to assess the effect of inhaled nitric oxide on platelet aggregation have not yet been reported. The tests were carried out in an animal model of shock in two 10-h periods. During the first 10 h, endotoxin was infused and the inhibition of platelet aggregation was evaluated; following the termination of endotoxin infusion, the restoration of platelet aggregation was assessed for 10 h. A total of 30 pigs were used (NO group, N = 14; control, N = 16). In the NO group, nitric oxide inhalation (30 ppm) was started 3 h after endotoxin infusion and continued until the end of the study. Treatment with NO selectively decreased pulmonary artery pressure at 4 (p = 0.002) and 8 h (p = 0.05) of the experiment as compared to the control. Endotoxin significantly reduced platelet aggregation, as indicated by the decreased activity of platelet receptors: ASPI, ADP, collagen, and TRAP during the experiment (p